Open AccessProportion and determinants of tuberculosis among human immunodeficiency virus-positive patients attending the antiretroviral therapy center attached to a Medical College in South India
Author(s) -
Vandana Hiregoudar,
Bellara Raghavendra,
Aravind Karinagannavar,
Wahid Ali Khan,
Sneha Kamble,
T. Gangadhara Goud
Publication year - 2016
Publication title -
journal of family and community medicine/maǧalaẗ ṭib al-usraẗ wa al-muǧtamaʼ
Language(s) - English
Resource type - Journals
eISSN - 2229-340X
pISSN - 1319-1683
DOI - 10.4103/2230-8229.181009
Subject(s) - medicine , tuberculosis , transmission (telecommunications) , demography , human immunodeficiency virus (hiv) , pandemic , pediatrics , disease , immunology , covid-19 , infectious disease (medical specialty) , pathology , electrical engineering , sociology , engineering
The human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) pandemic has caused a re-emergence of tuberculosis (TB). In persons infected with both HIV and TB, the lifetime risk of developing TB disease is 50-70% compared to 10% in HIV-negative individuals. India has world's 3(rd) highest HIV burden and is also one of the countries endemic for TB, so the country faces a dual epidemic of HIV and TB.